Frost Trusts Amend OPKO Health Stake
Ticker: OPK · Form: SC 13D/A · Filed: Nov 15, 2024 · CIK: 944809
| Field | Detail |
|---|---|
| Company | Opko Health, INC. (OPK) |
| Form Type | SC 13D/A |
| Filed Date | Nov 15, 2024 |
| Risk Level | medium |
| Pages | 7 |
| Reading Time | 9 min |
| Key Dollar Amounts | $0.01, $1.455, $1.6199, $583,501.93 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 13D-filing, ownership-change, amendment
Related Tickers: OPK
TL;DR
Frost trusts updated their OPKO Health stake. Watch for changes.
AI Summary
Frost Gamma Investments Trust and Frost Nevada Investments Trust, managed by Phillip Frost, MD, have filed an amendment (No. 25) to their Schedule 13D for OPKO Health, Inc. The filing, dated November 15, 2024, indicates a change in their beneficial ownership of OPKO Health's common stock. The specific details of the change in holdings or the total percentage owned are not explicitly stated in this excerpt.
Why It Matters
This filing signals potential shifts in significant ownership of OPKO Health, which could influence the company's stock performance and strategic direction.
Risk Assessment
Risk Level: medium — Schedule 13D filings often indicate significant investor activity, which can lead to price volatility.
Key Numbers
- 25 — Amendment Number (Indicates this is the 25th update to the filing.)
Key Players & Entities
- Frost Gamma Investments Trust (company) — Filing entity
- Frost Nevada Investments Trust (company) — Filing entity
- OPKO Health, Inc. (company) — Subject company
- Phillip Frost, MD (person) — Manager of filing entities
- Camielle Green (person) — Authorized person to receive notices
FAQ
What specific changes in beneficial ownership are detailed in this amendment?
This excerpt does not provide the specific details of the changes in beneficial ownership, only that an amendment (No. 25) has been filed.
Who manages the Frost Gamma Investments Trust and Frost Nevada Investments Trust?
The filing indicates that Phillip Frost, MD, is associated with these trusts, and Camielle Green is the Associate General Counsel, Secretary for OPKO Health, Inc.
What is the CUSIP number for OPKO Health, Inc. common stock?
The CUSIP number for OPKO Health, Inc. common stock is 68375N103.
When was this Schedule 13D/A filing submitted?
The filing was submitted on November 15, 2024.
What is the business address for OPKO Health, Inc.?
The business address for OPKO Health, Inc. is 4400 Biscayne Blvd., Miami, FL 33137.
Filing Stats: 2,133 words · 9 min read · ~7 pages · Grade level 8.8 · Accepted 2024-11-15 16:39:33
Key Financial Figures
- $0.01 — me of Issuer) Common Stock, par value $0.01 per share (Title of Class of Securiti
- $1.455 — the open market at prices ranging from $1.455 to $1.6199 per share for an aggregate p
- $1.6199 — market at prices ranging from $1.455 to $1.6199 per share for an aggregate purchase pri
- $583,501.93 — gregate purchase price of approximately $583,501.93 , as set forth below: Date Shares of
Filing Documents
- pfro20241112_sc13da.htm (SC 13D/A) — 105KB
- 0001437749-24-035504.txt ( ) — 106KB
(a)-(d) is deleted in its entirety and replaced with the following text
Item 5 (a)-(d) is deleted in its entirety and replaced with the following text: (a)-(b) Gamma Trust directly beneficially owns 211,612,405 shares of Common Stock. The 211,612,405 total shares of Common Stock beneficially owned by Gamma Trust constitute approximately 31.5% of the Issuer's outstanding shares of Common Stock, based upon 672,800,270 shares of Common Stock outstanding as of November 13, 2024 as communicated by the Issuer to the Reporting Person. Dr. Frost is the sole trustee of Gamma Trust and holds sole voting and dispositive power with respect to 211,612,405 shares of Common Stock. Frost Nevada directly beneficially owns 30,127,177 shares of Common Stock. The 30,127,177 total shares of Common Stock beneficially owned by Frost Nevada constitute approximately 4.5% of the Issuer's outstanding shares of Common Stock, based upon 672,800,270 shares of Common Stock outstanding as of November 13, 2024 as communicated by the Issuer to the Reporting Person. Dr. Frost is the sole trustee of Frost Nevada and holds sole voting and dispositive power with respect to 30,127,177 shares of Common Stock. Dr. Frost, as the sole trustee of Gamma Trust, may be deemed to beneficially own the 211,612,405 shares of Common Stock beneficially owned by Gamma Trust. Dr. Frost, as the sole trustee of Frost Nevada, may be deemed to beneficially own the 30,127,177 shares of Common Stock beneficially owned by Frost Nevada. In addition, the Phillip and Patricia Frost Philanthropic Foundation, Inc., which is controlled by Dr. Frost and his wife, owns 2,851,830 shares of Common Stock. Dr. Frost individually owns 3,068,951 shares of Common Stock and has stock options to acquire 2,800,000 shares of Common Stock, which are exercisable within 60 days of the date hereof, and has sole voting and dispositive power over each. The 250,460,363 shares of Common Stock beneficially owned by Dr. Frost constitute approximately 37.1% of the Issuer's outstanding shares of Common Stock, based upon (i)
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Frost Gamma Investments Trust Dated: November 15, 2025 By: /s/ Phillip Frost, M.D. Name: Phillip Frost, M.D. Title: Sole Trustee Frost Nevada Investments Trust Dated: November 15, 2025 By: /s/ Phillip Frost, M.D. Name: Phillip Frost, M.D. Title: Sole Trustee Dated: November 15, 2025 By: /s/ Phillip Frost, M.D. Name: Phillip Frost, M.D. Title: Phillip Frost, M.D., Individually